Serum and Cerebrospinal Fluid Autoantibodies in Patients with Neuropsychiatric Lupus Erythematosus. Implications for Diagnosis and Pathogenesis

Hilda Fragoso-Loyo, Javier Cabiedes, Alejandro Orozco-Narváez et al. · 2008

Read Serum and Cerebrospinal Fluid Autoantibodies in Patients with Neuropsychiatric Lupus Erythematosus. Implications for Diagnosis and Pathogenesis by Hilda Fragoso-Loyo, Javier Cabiedes, Alejandro Orozco-Narváez et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0003347.txt.

Description

Hilda Fragoso-Loyo and co-authors test antibody measures in lupus that affects the brain in this 2008 PLOS ONE paper. Lupus, or systemic lupus erythematosus, can involve the brain and nerves, but that diagnosis is hard and unsure. Past work tried to link some serum antibodies to those brain symptoms. The team assess those antibodies in blood and spinal fluid.

Readers get a check on which autoantibodies track with neuropsychiatric lupus, and what that means for diagnosis and cause. Brain lupus has few firm tests, so even a partial marker can aid doctors who must act on weak signs.

Catalog record

CREATORHilda Fragoso-Loyo, Javier Cabiedes, Alejandro Orozco-Narváez et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE43 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0003347

Browse the full library · About the Tower of Babel